Mood Disorders
IMPROVING METABOLIC PARAMETERS OF ANTIPSYCHOTIC CHILD TREATMENT – Multi-site Study (IMPACT-MS) The goal of this study is to find better treatments for children who have gained weight while taking antipsychotic medication Read more >> PREVENT: Metformin Mitigation Of Atypical Antipsychotic-Induced Metabolic Dysregulation In Adolescent YouthsThe purpose of this study is to determine whether starting metformin in conjunction with a second-generation antipsychotic (SGA) and providing information about healthy eating and activity will prevent or reduce the amount of weight gain and the metabolic changes typically seen with second-generation antipsychotic medication. Read more >> Ages: 10 - 17 years |
|
Related institutional links
Loading
Sections
|
We strive to make our web site clear and easy to navigate. If, however, you encounter any problem with this site, please email the web manager. |
|
